I would like a discussion comparing the pros and cons of Pfizer's settlement cost vs. taking control of ILNS outright; buying controlling interest in the shares. I think the settlement cost expectations for them are a bit on the wild side when it might be cheaper for Pfizer just to buy up shares. They will do which ever is cheaper.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.